SHIMIZU; Kanako

Patent Applications and Registrations

Patent applications and USPTO patent grants for SHIMIZU; Kanako.The latest application filed is for "combined use of artificial adjuvant vector cells and an immunostimulant".

Company Profile

1.4.17

SHIMIZU; Kanako - Saitama JP
Shimizu; Kanako - Wako JP
SHIMIZU; Kanako - Wako-shi JP
Shimizu; Kanako - Yokohama JP
SHIMIZU; Kanako - Yokohama-shi JP
Shimizu; Kanako - Kanagawa JP
Shimizu; Kanako - Niiza JP
Shimizu, Kanako - Higashishinbashi JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combined Use Of Artificial Adjuvant Vector Cells And An Immunostimulant App 20220296705 - FUJII; Shinichiro ; et al.	2022-09-22
Cell Capable Of Activating Immune System, And Pharmaceutical Composition Containing Said Cell App 20220251574 - FUJII; Shinichiro ; et al.	2022-08-11
Adjuvant composition and use thereof Grant 11,382,973 - Fujii , et al. July 12, 2	2022-07-12
METHOD FOR TREATING CANCER USING ARTIFICIAL ADJUVANT CELL (aAVC) App 20220016239 - OHSUMI; Keisuke ; et al.	2022-01-20
Adjuvant Composition And Use Thereof App 20190328870 - FUJII; Shinichiro ; et al.	2019-10-31
Memory invariant NKT cell marker Grant 10,416,160 - Fujii , et al. Sept	2019-09-17
Modified Immunocyte, Method For Producing Modified Immunocyte And Utilization Thereof App 20180044631 - FUJII; Shin-ichiro ; et al.	2018-02-15
Cell for use in immunotherapy which contains modified nucleic acid construct encoding wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct Grant 9,783,821 - Fujii , et al. October 10, 2	2017-10-10
Memory Invariant Nkt Cell Marker App 20170227540 - FUJII; Shin-ichiro ; et al.	2017-08-10
Method For Analysis Of Nkt Cell Function App 20160195530 - FUJII; Shin-ichiro ; et al.	2016-07-07
Cell For Use In Immunotherapy Which Contains Modified Nucleic Acid Construct Encoding Wilms Tumor Gene Product Or Fragment Thereof, Method For Producing Said Cell, And Said Nucleic Acid Construct App 20140179004 - Fujii; Shin-ichiro ; et al.	2014-06-26
Immunotherapeutic Method Using Artificial Adjuvant Vector Cells That Co-express Cd1d And Target Antigen App 20130189302 - FUJII; Shin-ichiro ; et al.	2013-07-25
IMMUNOTHERAPEUTIC METHOD USING ALLO-CELLS WHICH CO-EXPRESS CD1d AND TARGET ANTIGEN App 20110280895 - Fujii; Shin-ichiro ; et al.	2011-11-17
In Vitro Differentiation/induction Of Lymphocyte From Stem Cell Having Genotype Provided After Gene Reconstitution App 20110020932 - Wakao; Hiroshi ; et al.	2011-01-27
Method Of Evaluating Human Dentritic Cells And Human Cell Immunotherapeutic Agent App 20100330057 - Fujii; Shin-ichiro ; et al.	2010-12-30
IMMUNOTHERAPY BY USING CELL CAPABLE OF CO-EXPRESSING TARGET ANTIGEN AND CD1d AND PULSED WITH CD1d LIGAND App 20100233215 - Fujii; Shin-ichiro ; et al.	2010-09-16
Method For Analysis Of Nkt Cell Function App 20090233323 - Fujii; Shin-ichiro ; et al.	2009-09-17
Fermented foods and process for producing the same App 20070031536 - Kudo; Satoshi ; et al.	2007-02-08
Fermented foods and process for producing the same App 20040121042 - Kudo, Satoshi ; et al.	2004-06-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.